What are the risks associated with a single bilobed placenta in a twin pregnancy?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 5, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Risks of a Bilobed (Bipartite) Placenta in Monochorionic Twin Pregnancy

A bilobed placenta in monochorionic twins is associated with significantly increased complications, particularly twin-twin transfusion syndrome (TTTS) occurring in 60% of cases, selective intrauterine growth restriction (sIUGR) in 20%, and creates substantial technical difficulties for fetal interventions when needed. 1

Key Clinical Risks

High Rate of Twin-Specific Complications

  • TTTS develops in 60% of monochorionic twins with bipartite placenta, which is substantially higher than the baseline 9% TTTS rate in standard monochorionic pregnancies 1, 2
  • Selective intrauterine growth restriction occurs in 20% of these cases 1
  • Severe fetal malformations are seen in 20% of affected pregnancies 1
  • The overall fetal survival rate at birth is 90%, but neonatal survival drops to only 66.63% due to complications 1

Surgical and Intervention Challenges

  • Fetal interventions are indicated in 100% of bipartite placenta cases, but technically feasible in only 60% due to poor surgical conditions created by the separated placental masses 1
  • The spatial separation of placental lobes makes fetoscopic laser coagulation of vascular anastomoses extremely difficult when treating TTTS or other complications 1
  • This technical limitation significantly impacts the ability to provide definitive treatment for life-threatening conditions 1

Diagnostic Pitfall: Mimics Dichorionic Placentation

  • A critical diagnostic error can occur because two separate placental masses on ultrasound may falsely suggest dichorionic (lower-risk) pregnancy when the pregnancy is actually monochorionic (higher-risk) 3
  • The presence of two distinct placental masses with separate cord insertions has lower specificity for determining chorionicity, particularly in the second trimester 3
  • Always confirm monochorionicity by identifying the T-sign at 11-14 weeks gestation, which is the most specific ultrasound marker, rather than relying on placental mass appearance alone 4, 3

Underlying Pathophysiology

  • Monochorionic twins inherently carry over 2-fold higher perinatal mortality compared to dichorionic twins (7.6% vs 1.6% fetal demise rate) due to shared placental circulation with vascular anastomoses 4
  • Bipartite placenta represents an extreme form of unequal placental sharing, which disrupts the normal compensatory mechanisms of intertwin vascular connections 2
  • The separated placental lobes create more elaborate blood exchange patterns that can paradoxically worsen hemodynamic imbalances between twins 2

Management Implications

  • Intensive surveillance every 2 weeks starting at 16 weeks is mandatory for all monochorionic pregnancies, with even closer monitoring warranted when bipartite placenta is identified 4
  • Early referral to a tertiary fetal therapy center is essential given the near-universal need for intervention and technical complexity 1
  • Counseling should address the 33% neonatal mortality risk and high likelihood of requiring complex fetal procedures 1
  • If intervention becomes impossible due to placental anatomy, umbilical cord coagulation for selective feticide may be the only option to protect the healthier co-twin, with 83% survival and 92% normal development rates 2

References

Research

Two separate placental masses on ultrasound do not always indicate a dichorionic pregnancy.

Journal of gynecology obstetrics and human reproduction, 2020

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Related Questions

Do monochorionic (mo) twins have 2 placentas?
What are the key ultrasound (US) differences between monochorionic-diamniotic (MCDA) gestation and dichorionic-diamniotic (DCDA) gestation?
What is the most appropriate next step in managing a 24-week pregnant patient with monochorionic twin pregnancy and twin-to-twin transfusion syndrome (TTTS)?
At 19 weeks gestation, with two anterior placental masses and an intertwin membrane measuring 2.1 mm, are the twins dichorionic‑diamniotic or monochorionic‑diamniotic?
What is the most appropriate next step in managing a 12-week pregnant patient with a monochorionic twin pregnancy and evidence of twin-to-twin transfusion syndrome (TTTS)?
What is the appropriate workup for a patient with elevated platelet count (thrombocytosis)?
Can furosemide (Lasix) increase gout attacks in a patient being treated for hypertension or heart failure who has gout or hyperuricemia?
In an otherwise healthy pediatric patient with a solitary non‑tender, mobile lymph node presumed reactive, when should a follow‑up ultrasound be performed?
Does dialysis effectively remove potassium in patients with renal failure and hyperkalemia?
Is meloxicam safe for use in patients with chronic kidney disease, and what dose and monitoring are recommended?
A postoperative splenectomy patient with recurrent intestinal obstruction presenting with abdominal distention, pain, rigidity, sluggish bowel sounds, stable vital signs, and abdominal X‑ray showing multiple air‑fluid levels: what is the next step in management?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.